SoundBite Crossing System Peripheral Gen 2 Receives CE Mark Approval

 

December 18, 2018—SoundBite Medical Solutions Inc. announced that it has received European CE Mark approval for its SoundBite Crossing System Peripheral Gen 2, an improved version of its shockwave-based technology platform intended for the treatment of peripheral chronic total occlusions. The company plans to commercialize the device, which features an improved console and guidewire, in Europe and later in North America.

SoundBite develops products in the field of vessel preparation for the management and treatment of calcified and occlusive lesions in peripheral and coronary arterial diseases.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.